山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (10): 98-105.doi: 10.6040/j.issn.1671-7554.0.2024.0492
• 临床医学 • 上一篇
杨宝珠1,黄书苑1,于鑫鑫1,邓艳2,韩鹏熙3,刘晓龙4,王锡明1
YANG Baozhu1, HUANG Shuyuan1, YU Xinxin1, DENG Yan2, HAN Pengxi3, LIU Xiaolong4, WANG Ximing1
摘要: 目的 探究基于冠状动脉CT血管成像(coronary computed tomography angiography, CCTA)的冠状动脉周围脂肪衰减指数(fat attenuation index, FAI)对冠状动脉慢性全闭塞病变(chronic total occlusion, CTO)再通的预测价值。 方法 回顾性分析2012年11月至2023年6月期间行CCTA检查并接受经皮冠状动脉介入(percutaneous coronary intervention, PCI)治疗的冠状动脉完全闭塞患者(n=204)的临床资料,根据手术结果分为成功组(n=144)与失败组(n=60)。记录并分析两组患者的临床资料,闭塞段血管FAI,CTO病变的CCTA形态特征,包括病变部位[右冠状动脉(right coronary artery, RCA)、左前降支(left anterior descending artery, LAD)、左回旋支(left circumflex artery, LCX)]、病变长度、病变CT值、病变钙化斑块的体积、病变入口处的残端形态、病变弯曲角度是否>45°、病变是否为负性重构,并进行两组间比较。通过多因素Logistic回归分析筛选影响CTO病变再通的独立因素,并分别建立传统形态学特征模型及联合形态学特征和FAI的联合模型。通过受试者工作特征(receiver operating characteristic, ROC)曲线评价各模型的预测性能。 结果 两组间闭塞段FAI[(-82.33±10.61)HU vs.(-71.70±10.91)HU,P<0.001]、闭塞段CT值[69.85(55.95,86.25)HU vs. 58.25(47.00,72.83)HU,P<0.001]、闭塞段血管的钙化体积[20.92(2.25,52.80)mm3 vs. 5.69(0.00,25.75)mm3,P<0.001]、闭塞段长度[23.60(13.90,34.50)mm vs. 14.65(9.43,19.60)mm,P<0.001] 等差异均有统计学意义;其中,闭塞段长度>23.05 mm、闭塞段FAI<-77.50 HU、闭塞段CT值>58.15 HU及闭塞血管负性重构是CTO病变再通失败的独立预测因素,将以上三种形态学特征因素建立传统形态学特征模型,传统形态学特征模型联合闭塞段FAI建立联合模型。联合模型的预测价值优于传统形态学特征模型的预测价值,AUC分别为0.857、0.787,P<0.001。 结论 FAI可以作为预测冠状动脉慢性全闭塞病变PCI手术结果的一个新的预测指标;在传统的影像学特征基础上,FAI能为CTO患者手术结果的预测提供新的增量价值。
中图分类号:
[1] Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding principles for chronic total occlusion percutaneous coronary intervention[J]. Circulation, 2019, 140(5): 420-433. [2] Stone GW. Percutaneous coronary intervention of chronic total occlusions: conquering the final frontier[J]. JACC Cardiovasc Interv, 2018, 11(14): 1336-1339. [3] Yassin F, Khan J, Mozid A, et al. The utility of CT coronary angiography in chronic total occlusion percutaneous coronary intervention[J]. Eur Cardiol, 2023, 18: e48. doi:10.15420/ecr.2022.61. [4] 田晋帆, 邢浩然, 张丽君, 等. 经皮冠状动脉介入治疗冠状动脉慢性完全闭塞病变面临的思考与挑战 [J]. 中国循环杂志, 2023, 38(10): 1093-1097. TIAN Jinfan, XING Haoran, ZHANG Lijun, et al. Critical thinking and challenges of percutaneous coronary intervention for chronic total occlusive lesions of the coronary arteries [J]. Chinese Circulation Journal, 2023, 38(10): 1093-1097. [5] Yu CW, Lee HJ, Suh J, et al. Coronary computed tomography angiography predicts guidewire crossing and: Korean multicenter CTO CT registry score as a tool for assessing difficulty in chronic total occlusion percutaneous coronary intervention[J]. Circ Cardiovasc Imaging, 2017, 10(4): e005800. doi:10.1161/CIRCIMAGING.116.005800. [6] Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20, 000-patient EuroCTO registry: the EuroCTO(CASTLE)score[J]. JACC Cardiovasc Interv, 2019, 12(4): 335-342. [7] Fujino A, Otsuji S, Hasegawa K, et al. Accuracy of J-CTO score derived FromComputed tomography versus angiography to predict successful percutaneous coronary intervention[J]. JACC Cardiovasc Imaging, 2018, 11(2 Pt 1): 209-217. [8] Opolski MP, Achenbach S, Schuhbäck A, et al. Coronary computed tomographic prediction rule for time-efficient guidewire crossing through chronic total occlusion: insights from the CT-RECTOR multicenter registry(Computed Tomography Registry of Chronic Total Occlusion Revascularization)[J]. JACC Cardiovasc Interv, 2015, 8(2): 257-267. [9] 梁士楚, 白彦琳, 张静, 等. 成功开通冠状动脉慢性完全闭塞病变的冠状动脉造影影像学影响因素的Meta分析 [J]. 中国循证医学杂志, 2023, 23(8): 908-915. LIANG Shichu, BAI Yanlin, ZHANG Jing, et al. The angiographic predictors of successful chronic total occlusion percutaneous coronary intervention: a meta-analysis [J]. Chinese Journal of Evidence-Based Medicine, 2023, 23(8): 908-915. [10] Napoli G, Pergola V, Basile P, et al. Epicardial and pericoronary adipose tissue, coronary inflammation, and acute coronary syndromes[J]. J Clin Med, 2023, 12(23): 7212. doi:10.3390/jcm12237212. [11] 于亚妮, 刘昱圻, 陈韵岱. 血管周围脂肪组织及血管炎症在冠心病中的研究进展 [J]. 中国心血管杂志, 2021, 26(3): 294-298. YU Yani, LIU Yuqi, CHEN Yundai. Research progress of perivascular adipose tissue and vascular inflammation in coronary heart disease [J]. Chinese Journal of Cardiovascular Medicine, 2021, 26(3): 294-298. [12] Abdelrahman KM, Chen MY, Dey AK, et al. Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 76(10): 1226-1243. [13] Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk(the CRISP CT study): a post-hoc analysis of prospective outcome data[J]. Lancet, 2018, 392(10151): 929-939. [14] Sugiyama T, Kanaji Y, Hoshino M, et al. Determinants of pericoronary adipose tissue attenuation on computed tomography angiography in coronary artery disease[J]. J Am Heart Assoc, 2020, 9(15): e016202. doi:10.1161/JAHA.120.016202. [15] Tran P, Phan H, Shah SR, et al. Applied pathology for interventions of coronary chronic total occlusion[J]. Curr Cardiol Rev, 2015, 11(4): 273-276. [16] Luo C, Huang MP, Li JL, et al. Predictors of interventional success of antegrade PCI for CTO[J]. JACC Cardiovasc Imaging, 2015, 8(7): 804-813. [17] Antonopoulos AS, Sanna F, Sabharwal N, et al. Detecting human coronary inflammation by imaging perivascular fat[J]. Sci Transl Med, 2017, 9(398): eaal2658. doi:10.1126/scitranslmed.aal2658. [18] Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO(Multicenter CTO Registry in Japan)score as a difficulty grading and time assessment tool[J]. JACC Cardiovasc Interv, 2011, 4(2): 213-221. [19] Alessandrino G, Chevalier B, Lefèvre T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion[J]. JACC Cardiovasc Interv, 2015, 8(12): 1540-1548. [20] 高扬, 吕滨. 冠状动脉CT血管成像最新临床应用推荐及诊断规范[J]. 中华放射学杂志, 2022, 56(10): 1160-1164. GAO Yang, LYU Bin. The latest clinical application recommendation and diagnostic criteria of coronary CT angiography[J]. Chinese Journal of Radiology, 2022, 56(10): 1160-1164. [21] Wang R, He Y, Xing HR, et al. Inclusion of quantitative high-density plaque in coronary computed tomographic score system to predict the time of guidewire crossing chronic total occlusion[J]. Eur Radiol, 2022, 32(7): 4565-4573. [22] Sagris M, Antonopoulos AS, Simantiris S, et al. Pericoronary fat attenuation index-a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis[J]. Eur Heart J Cardiovasc Imaging, 2022, 23(12): e526-e536. [23] Xi Y, Huang L, Hao JH, et al. Predictive performance of the perivascular fat attenuation index for interventional antegrade percutaneous coronary intervention for chronic total occlusion[J]. Eur Radiol, 2023, 33(5): 3041-3051. [24] Akoumianakis I, Antoniades C. The interplay between adipose tissue and the cardiovascular system: is fat always bad?[J]. Cardiovasc Res, 2017, 113(9): 999-1008. [25] Goeller M, Achenbach S, Marwan M, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects[J]. J Cardiovasc Comput Tomogr, 2018, 12(1): 67-73. |
[1] | 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69-72. |
[2] | 张华,王培源,常娜,许天旗,袁宪顺,王锡明. 不同心动周期冠状动脉CT- FFR差异及其影响因素[J]. 山东大学学报 (医学版), 2023, 61(7): 55-62. |
[3] | 赵古月,尚靳,侯阳. 人工智能在冠状动脉CT血管成像的应用进展[J]. 山东大学学报 (医学版), 2023, 61(12): 30-35. |
[4] | 张润知,顾慧,李亚妮,杨世锋,高艳,王箬芃,王锡明. 449例患者冠状动脉周围脂肪衰减指数与CT高危斑块及狭窄程度的关联[J]. 山东大学学报 (医学版), 2023, 61(1): 27-31. |
[5] | 张伟,赵红艳,杜凤立,苏国英. 182例急性ST段抬高型心肌梗死患者术后30 d冠脉慢血流/无复流危险因素分析[J]. 山东大学学报 (医学版), 2019, 57(11): 9-15. |
[6] | 刘怡. 替罗非班联合IABP对冠脉复杂病变患者PCI术后的近期疗效观察[J]. 山东大学学报(医学版), 2014, 52(11): 45-48. |
[7] | 唐振旺. 不稳定型心绞痛介入治疗后基质金属蛋白酶9的表达改变对预后的影响[J]. 山东大学学报(医学版), 2012, 50(2): 120-. |
[8] | 辛辉1,2,巩会平3,张蕊2,康维强4,葛志明1,张运1. PCI对女性冠心病的临床价值及术前服用β-受体阻滞剂的作用[J]. 山东大学学报(医学版), 2010, 48(4): 98-. |
[9] | 徐宁宇 王磊 郝恩魁 苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2009, 47(6): 69-72. |
[10] | . 冠状动脉介入诊疗术患者造影剂肾病的危险因素研究[J]. 山东大学学报(医学版), 2009, 47(10): 98-101. |
|